Australian clinicians describe 40 cases of tattoo-associated uveitis

Published on February 18, 2026
The previously rare condition has become a regular fixture of uveitis clinics in Australia – a nation where one in four people have tattoos
Continue reading on website
Other news

Glaukos Reports Fourth Quarter and Full Year 2025 Financial Results

February 18, 2026
ALISO VIEJO, Calif.—Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, has announced its fourth quarter and full year 2025 financial results. Net sales in the fourth quarter of 2025 climbed to $143.1 million, a 36 percent increase (34 percent in constant curr

New PPP for POAG Suspects Refines Risk Factors and Foregrounds SLT

February 19, 2026
The 2026 PPP for POAG suspects states that the decision to treat depends on IOP and other risk factors. Treatment should also be initiated upon evidence of conversion to POAG, including characteristic optic nerve changes, abnormalities on circumpapillary RNFL or macular ganglion cell layer imaging or visual field defects. SLT is recommended over drops as the first-line option. Click image to enlar